Literature DB >> 8883553

Glaucoma and visual outcome in central retinal vein occlusion.

J Moisseiev1, H Desatnik, Y Cohen, A Lusky, S Melamed.   

Abstract

Glaucoma is a recognized risk factor for central retinal vein occlusion. The authors retrospectively reviewed charts of fifty patients with central vein occlusion examined over a 5-year period. The visual outcome and clinical characteristics of eyes with and without glaucoma were compared. There were 32 eyes without glaucoma and 18 eyes with glaucoma. Final visual acuity of 20/100 or better was obtained in 22% of eyes with glaucoma, compared with 34% of eyes without glaucoma, and final visual acuity of finger counting and less was found in 56% and 22%, respectively (p = 0.02). The rate of ischemic occlusion was higher in the glaucoma group, 44% and 28% respectively, but the difference did not reach statistical significance. There was no difference in the rate of neovascular complications and macular edema between the two groups. The results suggest that glaucoma has an adverse effect on the visual outcome of eyes with central vein occlusion.

Entities:  

Mesh:

Year:  1996        PMID: 8883553     DOI: 10.1111/j.1600-0420.1996.tb00711.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion.

Authors:  O A Saatci; S T Ferliel; M Ferliel; S Kaynak; M H Ergin
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 2.  Neovascular Glaucoma.

Authors:  Shane J Havens; Vikas Gulati
Journal:  Dev Ophthalmol       Date:  2015-10-26

3.  Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion.

Authors:  Shiu-Chen Wu; Yung-Sung Lee; Wei-Chi Wu; Shirley H L Chang
Journal:  BMC Ophthalmol       Date:  2016-05-31       Impact factor: 2.209

4.  Neovascular glaucoma after central retinal vein occlusion in pre-existing glaucoma.

Authors:  Hsi-Fu Chen; Min-Chi Chen; Chi-Chun Lai; Ling Yeung; Nan-Kai Wang; Henry Shen-Lih Chen; Wan-Chen Ku; Shiu-Chen Wu; Shirley H L Chang; Lan-Hsin Chuang
Journal:  BMC Ophthalmol       Date:  2014-10-05       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.